http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009139486-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee1c19da359446fb5c4f0458a57b783d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1334
filingDate 2007-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c78fb30bd70e83645c43e91ba38816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617c7ea91aed464c6ce48498af079632
publicationDate 2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009139486-A
titleOfInvention Liquid crystal optical element and manufacturing method thereof
abstract Disclosed is a liquid crystal optical element having a low haze value in a transmissive state and excellent in reliability in which an increase in haze is suppressed even with respect to a mechanical impact. A method of manufacturing a liquid crystal optical element comprising a composite of a liquid crystal and a cured product and transmitting light when no voltage is applied, wherein at least one of the electrodes is formed on each inner surface of a pair of insulating substrates. A step of bonding the insulating substrate with the inner surfaces of the insulating substrates facing each other through the following liquid crystal composition, and the liquid crystal composition is sandwiched between the inner surfaces of the insulating substrate and the liquid crystal is aligned. And a step of forming the composite by curing the curable compound in the liquid crystal composition in a finished state. Liquid crystal composition: A liquid crystal composition comprising a nematic liquid crystal, a polyfunctional curable compound having a mesogenic structure, and a compound represented by the following formula (4). CH 2 = CH-COOR (4 ) However, R in the formula is a linear alkyl group having 10 to 30 carbon atoms, and the linear alkyl group may have a branched chain having 4 or less carbon atoms. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019035468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018124198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102413786-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110168051-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018124198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110168051-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170086579-A
priorityDate 2007-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448231578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449171544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415799999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87070309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426207781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135534491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407460699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13847850

Total number of triples: 39.